NCT05003388View on ClinicalTrials.gov

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS

PHASE1RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 26, 2021

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL

AlloRx

cultured allogeneic adult umbilical cord derived mesenchymal stem cells

Trial Locations (2)

16675

RECRUITING

Athens Beverly Hills Medical Group, Glyfada

Unknown

RECRUITING

Medical Surgical Associates Center, St John's

All Listed Sponsors
lead

The Foundation for Orthopaedics and Regenerative Medicine

OTHER